Xylem Inc.
XYL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,268,000 | $2,301,000 | $2,069,000 | $2,256,000 |
| % Growth | -1.4% | 11.2% | -8.3% | – |
| Cost of Goods Sold | $1,385,000 | $1,409,000 | $1,301,000 | $1,399,000 |
| Gross Profit | $883,000 | $892,000 | $768,000 | $857,000 |
| % Margin | 38.9% | 38.8% | 37.1% | 38% |
| R&D Expenses | $52,000 | $58,000 | $56,000 | $58,000 |
| G&A Expenses | $0 | $0 | $460,000 | $0 |
| SG&A Expenses | $474,000 | $503,000 | $460,000 | $507,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $23,000 | $26,000 | $21,000 | $25,000 |
| Operating Expenses | $549,000 | $587,000 | $537,000 | $590,000 |
| Operating Income | $334,000 | $305,000 | $231,000 | $267,000 |
| % Margin | 14.7% | 13.3% | 11.2% | 11.8% |
| Other Income/Exp. Net | -$37,000 | -$6,000 | -$14,000 | $108,000 |
| Pre-Tax Income | $297,000 | $299,000 | $217,000 | $375,000 |
| Tax Expense | $71,000 | $75,000 | $50,000 | $49,000 |
| Net Income | $227,000 | $226,000 | $169,000 | $326,000 |
| % Margin | 10% | 9.8% | 8.2% | 14.5% |
| EPS | 0.93 | 0.93 | 0.7 | 1.34 |
| % Growth | 0% | 32.9% | -47.8% | – |
| EPS Diluted | 0.93 | 0.93 | 0.69 | 1.34 |
| Weighted Avg Shares Out | 243,500 | 243,370 | 243,100 | 243,800 |
| Weighted Avg Shares Out Dil | 244,100 | 243,859 | 243,800 | 243,800 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6,000 | $9,000 | $8,000 | $9,000 |
| Depreciation & Amortization | $141,000 | $145,000 | $145,000 | $142,000 |
| EBITDA | $444,000 | $453,000 | $370,000 | $526,000 |
| % Margin | 19.6% | 19.7% | 17.9% | 23.3% |